Clinical trial
Cytokines as Biomarkers and Therapeutic Targets in Paraneoplastic Opsoclonus-Myoclonus Syndrome (OMS)
NCT00806182 is registered in ClinicalTrials.gov with National Pediatric Neuroinflammation Organization, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cytokines as Biomarkers and Therapeutic Targets in Paraneoplastic Opsoclonus-Myoclonus Syndrome (OMS)
- Lead sponsor
- National Pediatric Neuroinflammation Organization, Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2008
- Completion date
- December 31, 2016
- Enrollment
- 400 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.